BPA Call 36C25525A0007-36C25526N0056
- Exact Sciences Corporation, operating through its Exact Sciences Laboratories, LLC division, received a task order award valued at $3,453.96 from Veterans Integrated Service Network 15 on March 16, 2026, for Oncotype DX testing services supporting the Topeka Veterans Affairs Medical Center. This firm fixed-price delivery order is issued under a broader $1,071,290.72 blanket purchase agreement established between VISN 15 and Exact Sciences on March 16, 2025, which provides a framework for...
- Exact Sciences Corporation, operating through its Exact Sciences Laboratories, LLC division, was awarded a $24,258.80 firm fixed-price task order by Veterans Integrated Service Network 15 on March 16, 2026, in support of Oncotype DX testing services at the St. Louis Veterans Affairs Medical Center. This task order was issued under a larger blanket purchase agreement established on March 16, 2025, with a $1.07M ceiling value through March 15, 2027, which provides a framework for oncology...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a task order valued at $3,116 under a Blanket Purchase Agreement (BPA) call for Oncotype DX Testing Services by the Department of Veterans Affairs' Veterans Integrated Service Network 15 (VISN 15). The award, issued on March 16, 2026, with an ultimate completion date of March 15, 2027, is structured as a firm fixed-price contract with no set-aside designation. Performance will take place in Marion,...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, has been awarded a Firm Fixed Price task order under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule Blanket Purchase Agreement with the Department of Veterans Affairs Veterans Integrated Service Network 15. The contract, valued at $10,442.96, was awarded on March 16, 2026, with an ultimate completion date of March 15, 2027, and will be performed in Kansas City, MO. This...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a task order under a Blanket Purchase Agreement (BPA) for Oncotype DX testing services by Veterans Integrated Service Network 15 (VISN 15), a component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on March 16, 2026, carries a ceiling value of $31,328.88 with an ultimate completion date of March 15, 2027. The contract was issued without a set-aside designation,...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order on October 1, 2022, valued at $203,932.36 for Oncotype DX testing services to support the Department of Veterans Affairs' Veterans Integrated Service Network 7 (VISN 7). The contract, which will be completed by July 31, 2027, operates under a firm fixed-price arrangement with no set-aside designation, enabling VISN 7 to procure specialized genomic testing services at a competitive...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order valued at $594,081.12 for Oncotype gene expression breast cancer testing services by the Department of Veterans Affairs' Veterans Integrated Service Network 8 (VISN 8). The contract, awarded on May 15, 2022, operates under a firm fixed-price structure with an ultimate completion date of May 14, 2027, and will be performed in Tampa, Florida. This delivery order was issued without a...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order valued at $20,385.80 by Veterans Integrated Service Network 16 (VISN 16) on October 1, 2024, for Oncotype DX Breast Assay testing services. This firm fixed-price delivery order represents a task order call against the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule, under which Exact Sciences holds multiple blanket purchase agreements with the...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, received a firm fixed-price delivery order from Veterans Integrated Service Network 8 (VISN 8) on October 1, 2022, for gene expression testing services. The delivery order, valued at $932,881.14 with an ultimate completion date of February 5, 2026, is not designated as a set-aside procurement. Services will be performed in Orlando, Florida, and the award falls under the Medical Laboratory Testing and Analysis...
- Exact Sciences Corporation, operating through its Exact Sciences Laboratories, LLC division, received a $31,085.64 firm fixed-price Blanket Purchase Agreement (BPA) call from Veterans Integrated Service Network 17, a Veterans Health Administration organization, on June 5, 2023, with performance completion by June 4, 2024. The award was issued without a set-aside designation and falls under the General Services Administration's Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70053-36C25525A0007Blanket Purchase Agreement
- 36C25525A0007-36C25526N0056BPA Call
Exact Sciences Corporation received a $3,453.96 task order award on March 16, 2026, from Veterans Integrated Service Network 15 (VISN 15) for Oncotype DX testing services at the Leavenworth Department of Veterans Affairs Medical Center. This firm fixed-price delivery order falls under a blanket purchase agreement established on March 16, 2025, with a total ceiling value of $1,071,290.72 through March 15, 2027, which supports oncology diagnostic testing across seven VA medical facilities in the central United States. The award carries no set-aside designation and leverages Exact Sciences' proprietary gene expression profiling technology to assess cancer recurrence risk and treatment responsiveness for breast, prostate, and colorectal cancer patients. This task order is issued under the Medical Laboratory Testing and Analysis Services (FSS-621-II) General Services Administration Federal Supply Schedule, which enables federal agencies to procure specialized medical laboratory services through established framework agreements. Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, has established itself as a leading provider of oncology diagnostic testing to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks, as well as to the Defense Health Agency and Department of Defense medical systems. The company maintains multiple indefinite delivery vehicles totaling millions of dollars with federal healthcare agencies, reflecting sustained government demand for its specialized Oncotype DX assay services that support cancer treatment planning and patient outcomes across the Veterans Health Administration network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/22/26 |